U.S. Markets open in 4 hrs.

InVivo Therapeutics Holdings Corp. (NVIV)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.40+0.05 (+3.70%)
At close: 4:00PM EDT
People also watch
AVXLCURONCSADXSBCLI
  • k
    ken
    ken
    The upcoming investor conference is a forum for financial planners, economists, market analysts, economists, accountants and bankers. Will NVIV be able to toss the tired old slide presentation in favor of a new one aimed at the proper audience? Will the audience learn what an investment in NVIV can produce in 1, 2, 3 years? Will they learn about the risk of success and failure? Will they learn about PW of future net income under various assumptions? Will they learn about how/when NVIV will restart the trial? What about the trial has changed if anything? What are the updated results on conversions? What can be said about a marketing plan? How does the scaffold stack up sise-by-side with stem cell science/results?
  • L
    La
    La
    seems like NVIV is green every day lately. Who can explain this phenomenon?
  • m
    mark
    mark
    Hey I like it !! i am sitting in London thinking wow NVIV !
    I can't wait to get home to Boston and see NVIV at $2.75 in Oct! good thoughts to all inflicted ....this will work out in our favor !
  • D
    David
    David
    Here's the deal with this company. They are fast tracked by the FDA to only enroll 20 patients in their INSPIRE program and get a 25% improvement rate 6 months after the procedure has been completed. In the end of July, the company announced that patient 17 passed away which made every headline regarding this company. However, people did not actually read the article. Although patient 17 passed away, it was proven by an outside investigation that it had nothing to do with the device or the procedure. They also reported that after 6 months, 11 patients have reported back and 6/11 (54.5%!!) have improved after a half of a year. What makes this number even more interesting is that 6/20= 30%. Therefore, if none of the last 9 patients report improvements after 6 months, the company already met the threshold the FDA set for them. All that needs to be done is resume the program and get the last of the four patients enrolled and FDA approval is here! My price target by end of December is $9. I am currently very bullish, but it will be a long ride ahead of us.
  • A
    ANDREAS
    ANDREAS
    Looks like we will be getting an update on 26sept! Hopefully it will be Good News! Gluck to all longs!
  • F
    Fabio
    Fabio
    That's what we long are waiting for, I believe, and I hope that we are meeting with the FDA for the resumption of the study but also to clarify whether the FDA has accepted as the control arm proposed by Nviv and if the endpoint is confirmed to 25% of 20 patients
  • A
    ANDREAS
    ANDREAS
    Nviv has had decent volume for last few days maybe good news to follow?
  • d
    david graham
    david graham
    Its crystal clear that the scaffold provides benefit (certainly far above what's available currently for acute spinal cord injury)-with the pps so depressed wouldn't J & J/Stryker etc. not be interested in buying out In Vivo before the price goes far higher? they would have the resources to finish INSPIRE/market the scaffold once it achieves commercialization and even advance the scaffold to the Neural Stem Cell + Scaffold trial??
  • s
    saracen1866
    saracen1866
    Who's more inept, NVIV management or YAHOO ?????
  • F
    Fabio
    Fabio
    The volumes in the purchase are increasing and with them also the quotation, maybe soon we will have good news
  • M
    Michael
    Michael
    Interesting to see how short interest has decreased one million shares since June 2017.
    Let's see if there's further reduction at the end of the month.
  • o
    old
    old
    Someone has been buying some nice size lots.
  • k
    ken
    ken
    Hello...This morning I saw Jesi walking! Braces with a walker...WALKING!
  • D
    Dude
    Dude
    How many people collect $8,000 per work day to sit back and get literally nothing done? I believe that should be a form of criminal activity, especially when you are tasked with fiduciary responsibilities in a public company, and you are supposed to be a good steward of your investors' hard earned money. Precious time is being wasted in an unnecessary voluntary halting of a successful trial of a revolutionary medical device with no safety issues. Can someone hold this guy responsible or what? I'm not a fan of the ambulance chaser lawyers but someone needs to compel this loser to start acting like a real leader instead of a flunky.
  • d
    dj golio
    dj golio
    No manipulation of NVIV stock ever.........................Sell order for 12600 shares in place today since the opening bell with all buy orders well below that amount. Vermin at work again.
  • L
    Logan
    Logan
    Over $2 soon
  • c
    creedheed
    creedheed
    If dumb were dollars there'd be some rich MFers on here
  • R
    RickM
    RickM
    The Movie "It" is about a group of clowns doing horrific things and terrorizing innocent people. Much like MP and the board of directors of NVIV.
  • J
    Jnsnintrcptr
    Jnsnintrcptr
    The 39M market cap is just a mind blower...
    Wake up NVIV! Wake up! Time to start up again get the market cap over 100M.
  • S
    Steve
    Steve
    Wheres the news you birdbrain
    IT'S TIME FOR YOU TO RESIGN!!!!!!!!